Aurinia Pharmaceuticals Inc. (AUPH) Q3 2022 Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts
133.64K Followers

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET

Company Participants

Peter Greenleaf - President & Chief Executive Officer

Joe Miller - Chief Financial Officer

Conference Call Participants

Ed Arce - H.C. Wainwright

Joseph Schwartz - SVB Securities

Ken Cacciatore - Cowen & Company

Justin Kim - Oppenheimer & Company

Sahil Dhingra - RBC Capital Markets

David Martin - Bloom Burton

Maury Raycroft - Jefferies

Operator

Greetings, and welcome to Aurinia Pharmaceuticals Inc. Third Quarter 2022 Earnings Call. At this time all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, John Walbert [ph], Investor Relations for Aurinia Pharmaceuticals. Thank you. You may begin.

Unidentified Company Representative

Thank you, Melissa, and thank you all for joining today's call and webcast to discuss Aurinia's third quarter 2022 results. Joining me this morning to lead the call are Peter Greenleaf, President and Chief Executive Officer; Joe Miller, Chief Financial Officer. This morning Aurinia issued a press release announcing its financial results and recent operational highlights and filed its quarterly report on Form 10-Q. For more information, please refer to Aurinia’s filings with the US Securities and Exchange Commission, which are also available on Aurinia’s website at auriniapharma.com.

During this call, Aurinia may make forward-looking statements based on current expectations. These forward-looking statements are subject to a number of significant risks and uncertainties, and actual results may differ materially. For discussion of factors that could affect Aurinia’s future financial results and business, please refer to the disclosures in Aurinia’s press release and its quarterly report on Form 10-Q, along with Aurinia’s 10-K and all of our recent filings with the US Securities and Exchange Commission and Canadian

Recommended For You

Comments (4)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.